Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. News
  7. Summary
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Seagen : Insider at Seagen (SGEN) Makes Significant Sale of Stock

06/22/2021 | 02:20pm EDT


ę MT Newswires 2021
All news about SEAGEN INC.
05:41pSEAGEN : Q2 Loss Widens Amid Higher Revenue, Reaffirms Guidance -- Stock Up 2% A..
MT
05:33pSEAGEN : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
05:30pSEAGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
04:24pSEATTLE GENETICS : Q2 Earnings Snapshot
AQ
04:08pSEAGEN INC. : Results of Operations and Financial Condition (form 8-K)
AQ
04:08pSEAGEN : Earnings Flash (SGEN) SEAGEN Reports Q2 Revenue $388.5M, vs. Street Est..
MT
04:05pSEAGEN : Reports Second Quarter 2021 Financial Results
BU
12:11pEARNINGS REACTION HISTORY : Seagen Inc, 50.0% Follow-Through Indicator, 7.3% Sen..
MT
07/16SEAGEN : Morgan Stanley Adjusts Price Target on Seagen to $167 From $173, Mainta..
MT
07/15SEAGEN INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
More news
Financials (USD)
Sales 2021 1 490 M - -
Net income 2021 -430 M - -
Net cash 2021 2 337 M - -
P/E ratio 2021 -61,8x
Yield 2021 -
Capitalization 26 514 M 26 514 M -
EV / Sales 2021 16,2x
EV / Sales 2022 10,9x
Nbr of Employees 2 092
Free-Float 99,3%
Chart SEAGEN INC.
Duration : Period :
Seagen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEAGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 146,10 $
Average target price 185,61 $
Spread / Average Target 27,0%
EPS Revisions
Managers and Directors
Clay B. Siegall Chairman, President & Chief Executive Officer
Todd E. Simpson Chief Financial Officer
Vaughn B. Himes Chief Technical Officer
Roger D. Dansey Chief Medical Officer
Marc E. Lippman Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEAGEN INC.-16.58%26 514
MODERNA, INC.234.37%140 262
LONZA GROUP AG20.53%55 738
IQVIA HOLDINGS INC.36.95%47 028
CELLTRION, INC.-27.16%30 887
PHARMARON BEIJING CO., LTD.73.59%23 797